Robotic Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy.

Autor:	Rooks CO; Department of Surgery, University of Mississippi Medical Center, Jackson, MS, USA., Hughes T; Department of Surgery, University of Mississippi Medical Center, Jackson, MS, USA., Rodgers S; Department of Surgery, University of Mississippi Medical Center, Jackson, MS, USA., Brister K; Department of Surgery, Division of Surgical Oncology, University of Mississippi Medical Center, Jackson, MS, USA., Christopher WO; Department of Surgery, Division of Surgical Oncology, University of Mississippi Medical Center, Jackson, MS, USA., Orr WS; Department of Surgery, Division of Surgical Oncology, University of Mississippi Medical Center, Jackson, MS, USA.
Jazyk:	angličtina
Zdroj:	The American surgeon [Am Surg] 2023 Aug; Vol. 89 (8), pp. 3476-3477. Date of Electronic Publication: 2023 Mar 03.
DOI:	10.1177/00031348231161709
Abstrakt:	Cytoreductive surgery with heated intraperitoneal chemotherapy (CRS-HIPEC) is traditionally an open operation given the dissection required during cytoreduction. There are reports of minimally invasive HIPECs, but CRS to an accepted completeness of cytoreduction (CCR) has been described less frequently. We report a patient with metastatic low-grade mucinous appendiceal neoplasm (LAMN) to the peritoneum treated with robotic CRS-HIPEC. A 49-year-old male presented to our center following a laparoscopic appendectomy at an outside facility with final pathology showing LAMN. He had a peritoneal cancer index (PCI) score of 5 determined by diagnostic laparoscopy. Given the small amount of peritoneal disease, he was deemed a candidate for robotic CRS-HIPEC. Cytoreduction was completed robotically with a CCR score of 0. He then received HIPEC with mitomycin C. This case shows the feasibility of robotic-assisted CRS-HIPEC for select LAMNs. When appropriately selected, we advocate for the continued use of this minimally invasive approach.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu